MassBioEd Life Sciences Workforce 2020

June 2, 2020 1:00 PM - June 4, 2020 3:00 PM

Online Conference, Link will be sent in advance of the event.

Add to Calendar 6/2/2020 1:00:00 PM 6/4/2020 3:00:00 PM MassBioEd Life Sciences Workforce 2020 MassBioEd's Life Sciences Workforce Conference provides insights into the major trends affecting the industry in Massachusetts. This year, as the world adapts to conducting business remotely, topics will focus on the hiring effects of the COVID-19 pandemic and implications for industry operations. Attendees from academia and industry will convene remotely with expert panelists to address critical issues such as how the pandemic is affecting business, how to focus on recovery, including handling disrupted class schedules and the abrupt shutdown of graduate research projects, and how to build a flexible workforce. Breakout sessions will offer opportunities for networking and more in-depth discussion to share best practices. Influential leaders from universities, colleges, and industry will come together to work on building solutions to expand the workforce and create innovative pathways for candidates to develop skills and be better prepared for careers in the industry.  

Thank you to our Premier Sponsors: MilliporeSigma, Sanofi Genzyme, Thermo Fisher Scientific, and Third Rock Ventures!

Registration is free for MassBio Members and Non-Members.

Panels

Panel I: Best Practices in Current and Future Workforce Management - Hiring, Onboarding, Remote Work
Panel II: Adapting Biotechnology Higher Education for Remote Learning - Stop Gap Measures or Paradigm Shifts?
Panel III: Solving Issues in Managing Foreign-Born Talent During Pandemic

  Online Conference, Link will be sent in advance of the event.
Vice President/General Manager, Thermo Fisher Scientific
Christopher Murphy is Vice President and General Manager of Viral Vector Services in Thermo Fisher Scientific’s Pharma Services Group. Prior to joining Thermo Fisher, Chris served as chief operating officer for Brammer Bio, a leading viral vector/gene therapy CDMO. Chris has more than 30 years of experience in biopharmaceutical manufacturing, process development, plant operations, and quality system implementation. Prior to joining Brammer Bio, Chris served as general manager for the Sanofi-Genzyme Allston Landing site overseeing operations and leading an integrated remediation program associated with the consent decree. Chris has led gene therapy operations and recombinant protein manufacturing at Genzyme and Bioreliance and he began his career in viral vaccine development at American Cyanamid/Wyeth (now Pfizer) in Pearl River, NY. He has an M.Sc. in biochemistry at New York Medical College, and his B.Sc. in biology at Rutgers University.

Brought to you by